[Quality of life in DCIS patients after breast-conserving surgery plus adjuvant radiotherapy: conventional fractionated vs. hypofractionated radiotherapy, with and without boost]
- PMID: 33763718
- DOI: 10.1007/s00066-021-01764-7
[Quality of life in DCIS patients after breast-conserving surgery plus adjuvant radiotherapy: conventional fractionated vs. hypofractionated radiotherapy, with and without boost]
Comment on
-
Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.Lancet Oncol. 2020 May;21(5):685-698. doi: 10.1016/S1470-2045(20)30085-1. Epub 2020 Mar 20. Lancet Oncol. 2020. PMID: 32203696 Clinical Trial.
References
Literatur
-
- McCormick B, Winter K, Hudis C et al (2015) RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radio therapy with observation. J Clin Oncol 33:709–715 - DOI
-
- Haviland JS, Owen JR, Dewar JA et al (2013) The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow up results of two randomised controlled trials. Lancet Oncol 1:931–941
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources